Apr 8, 2025
Apr 8, 2025
Puzzle Medical Devices is Thrilled to Announce the Closing of its CAN$43 Million Round to Complete its Clinical Study Led by KF Matheson and Desjardins Capital
Jan 8, 2025
Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
Jan 7, 2025
Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population
Dec 11, 2024